Grand Wealth Management’s Yield10 Bioscience, Inc. Common Stock YTEN Stock Holding History

Grand Wealth Management’s Portfolio YTEN Stock Details YTEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-507	Closed	-$12.2K	–	72
2024 Q1	$12.2K	Buy	+507	New	+$3.19K	0.01%	65
2023 Q2	–	Sell	-1,178	Closed	-$78.1K	–	78
2023 Q1	$78.1K	Buy	+1,178	New	+$85.5K	0.05%	44

Grand Wealth Management's YTEN Position: Q2 2024 in Review

Grand Wealth Management sold out of Yield10 Bioscience, Inc. Common Stock (YTEN) in Q2 2024, closing a stake of 507 shares — an estimated $12.2K sold.

Grand Wealth Management first reported a position in YTEN in Q1 2023 and held it in 2 quarters. The position peaked at $78.1K in Q1 2023. 0 funds tracked by Wall St. Rank hold YTEN as of Q2 2024.

Grand Wealth Management reported no remaining Yield10 Bioscience, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Grand Wealth Management sold 507 Yield10 Bioscience, Inc. Common Stock shares in Q2 2024, an estimated $12.2K.
Grand Wealth Management first reported a position in Yield10 Bioscience, Inc. Common Stock in Q1 2023 and held it in 2 quarters.
Grand Wealth Management's Yield10 Bioscience, Inc. Common Stock position peaked at $78.1K in Q1 2023.
0 funds tracked by Wall St. Rank held Yield10 Bioscience, Inc. Common Stock as of Q2 2024.

Based on Grand Wealth Management's 13F filing for Q2 2024, filed 8 Aug 2024.